Benzinga’s Top Ratings Upgrades, Downgrades For August 9, 2023
Upgrades According to B. Riley Securities, the prior rating for Mirati Therapeutics Inc (NASDAQ:MRTX) was changed from Neutral…
Benzinga’s Top Ratings Upgrades, Downgrades For July 21, 2023
Upgrades For Vintage Wine Estates Inc (NASDAQ:VWE), Canaccord Genuity upgraded the previous rating of Sell to Hold. Vintage…
Morphic Presents New Biomarker Data At DDW 2023 Supporting MORF-057 Program In Ulcerative Colitis
Morphic Therapeutic (NASDAQ:MORF) today announced the presentation of new preclinical data in the MORF-057 IBD development program that are consistent with previous findings and add new support to mechanistic
More Than $47M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Morphic Therapeutic Raises $240M Via Secondary Share Sale Of 5.3M Shares At $45.00 Per Share
Morphic Holding, Inc. (NASDAQ:MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an underwritten public
Xerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Morphic Therapeutic’s Ulcerative Colitis Candidate Shows Clinically Meaningful Improvements Across Measures, Stock Soars
Morphic Therapeutic (NASDAQ:MORF) reported topline data from the main cohort of the open-label EMERALD-1 Phase 2a study of MORF-057, an oral…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Virios Therapeutics (NASDAQ:VIRI) shares moved upwards by 93.5% to $1.21 during Tuesday’s pre-market session. The market value…
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.